HDL infusion for the management of atherosclerosis: current developments and new directions.

Abstract

PURPOSE OF REVIEW Because human genetic studies and large clinical trials have demonstrated that HDL-cholesterol levels are not causally related to cardiovascular disease risk, attention has shifted toward the functional properties of HDL. Infusion of HDL mimetics containing apolipoprotein A-I remains a potential strategy to exploit the atheroprotective… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.